| 1 |
(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-y1] butanamide |
- |
- |
- |
- |
309 [1] 309 💬 |
| 2 |
(2s)-2-[(4r)-2-oxo-4-propylpyrrolidin-1-yl] butanamide |
- |
- |
- |
- |
309 [1] 309 💬 |
| 3 |
Brivaracetam |
Brivaracetam |
[1] D08879 D08879 💬 |
SV2A [1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
149 [2] 149, 309 💬 |
| 4 |
Brivaracetam 25 mg |
Brivaracetam |
[1] D08879 D08879 💬 |
SV2A [1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
309 [1] 309 💬 |
| 5 |
Brivaracetam 50 mg |
Brivaracetam |
[1] D08879 D08879 💬 |
SV2A [1] SV2A 💬 |
ECM-receptor interaction [1] ECM-receptor interaction |
309 [1] 309 💬 |
| 6 |
Brv 2.5 mg |
- |
- |
- |
- |
309 [1] 309 💬 |
| 7 |
Brv 25 mg |
- |
- |
- |
- |
309 [1] 309 💬 |
| 8 |
Brv 50 mg |
- |
- |
- |
- |
309 [1] 309 💬 |
| 9 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
| 10 |
Requip |
- |
- |
- |
- |
006 [2] 6 , 309 💬 |
| 11 |
Ropinirole |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 309 💬 |
| 12 |
Ropinirole hydrochloride |
Ropinirole |
[2] D00784 D00784, D08489 D08489 💬 |
DRD2 [3] DRD2, DRD3, DRD4 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [2] 6 , 309 💬 |
| 13 |
Ucb 34714 |
- |
- |
- |
- |
149 [2] 149, 309 💬 |